These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33803552)

  • 1. Thermosensitive Gels Used to Improve Microneedle-Assisted Transdermal Delivery of Naltrexone.
    Tobin KV; Fiegel J; Brogden NK
    Polymers (Basel); 2021 Mar; 13(6):. PubMed ID: 33803552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of microneedles-assisted in situ depot forming poloxamer gels for sustained transdermal drug delivery.
    Khan S; Minhas MU; Tekko IA; Donnelly RF; Thakur RRS
    Drug Deliv Transl Res; 2019 Aug; 9(4):764-782. PubMed ID: 30675693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial Approach of Thermosensitive Hydrogels and Solid Microneedles to Improve Transdermal Delivery of Valsartan: an In Vivo Proof of Concept Study.
    Nirmayanti N; Alhidayah A; Usman JT; Nur JF; Amir MN; Permana AD
    AAPS PharmSciTech; 2022 Nov; 24(1):5. PubMed ID: 36447099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone salt selection for enhanced transdermal permeation through microneedle-treated skin.
    Milewski M; Pinninti RR; Stinchcomb AL
    J Pharm Sci; 2012 Aug; 101(8):2777-86. PubMed ID: 22628183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Characterization of Spray-Dried Chitosan-Naltrexone Microspheres for Microneedle-Assisted Transdermal Delivery.
    Ogunjimi AT; Fiegel J; Brogden NK
    Pharmaceutics; 2020 May; 12(6):. PubMed ID: 32485999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microneedles assisted controlled and improved transdermal delivery of high molecular drugs via
    Khan S; Minhas MU; Singh Thakur RR; Aqeel MT
    Drug Dev Ind Pharm; 2022 Jun; 48(6):265-278. PubMed ID: 35899871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies.
    M A Fathalla Z; Vangala A; Longman M; Khaled KA; Hussein AK; El-Garhy OH; Alany RG
    Eur J Pharm Biopharm; 2017 May; 114():119-134. PubMed ID: 28126392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flux across [corrected] microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro.
    Banks SL; Pinninti RR; Gill HS; Crooks PA; Prausnitz MR; Stinchcomb AL
    Pharm Res; 2008 Jul; 25(7):1677-85. PubMed ID: 18449628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poloxamer 407 Based Gel Formulations for Transungual Delivery of Hydrophobic Drugs: Selection and Optimization of Potential Additives.
    Ullah KH; Raza F; Munawar SM; Sohail M; Zafar H; Zafar MI; Ur-Rehman T
    Polymers (Basel); 2021 Sep; 13(19):. PubMed ID: 34641190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride.
    Cho HJ; Balakrishnan P; Park EK; Song KW; Hong SS; Jang TY; Kim KS; Chung SJ; Shim CK; Kim DD
    J Pharm Sci; 2011 Feb; 100(2):681-91. PubMed ID: 20803575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution.
    Wei Y; Li C; Zhu Q; Zhang X; Guan J; Mao S
    Int J Pharm; 2020 Mar; 578():119184. PubMed ID: 32112932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel in situ forming hydrogel microneedles for transdermal drug delivery.
    Sivaraman A; Banga AK
    Drug Deliv Transl Res; 2017 Feb; 7(1):16-26. PubMed ID: 27562294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vehicle composition influence on the microneedle-enhanced transdermal flux of naltrexone hydrochloride.
    Milewski M; Stinchcomb AL
    Pharm Res; 2011 Jan; 28(1):124-34. PubMed ID: 20577787
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Hemelryck SV; Dewulf J; Niekus H; van Heerden M; Ingelse B; Holm R; Mannaert E; Langguth P
    Int J Pharm X; 2019 Dec; 1():100016. PubMed ID: 31517281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermosensitive Pluronic hydrogel: prolonged injectable formulation for drug abuse.
    Derakhshandeh K; Fashi M; Seifoleslami S
    Drug Des Devel Ther; 2010 Sep; 4():255-62. PubMed ID: 20957216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of skin resealing after insertion of microneedles in human subjects.
    Gupta J; Gill HS; Andrews SN; Prausnitz MR
    J Control Release; 2011 Sep; 154(2):148-55. PubMed ID: 21640148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of surfactants and pH on naltrexone (NTX) permeation across buccal mucosa.
    Rai V; Tan HS; Michniak-Kohn B
    Int J Pharm; 2011 Jun; 411(1-2):92-7. PubMed ID: 21443939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo studies for the passive transdermal delivery of low-dose naltrexone from a cream; detection of naltrexone and its active metabolite, 6β-naltrexol, using a novel LC Q-ToF MS assay.
    Dodou K; Armstrong A; Kelly I; Wilkinson S; Carr K; Shattock P; Whiteley P
    Pharm Dev Technol; 2015; 20(6):694-701. PubMed ID: 24785567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a codrug approach for sustained drug delivery across microneedle-treated skin.
    Ghosh P; Pinninti RR; Hammell DC; Paudel KS; Stinchcomb AL
    J Pharm Sci; 2013 May; 102(5):1458-67. PubMed ID: 23417751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Hydrogels for Microneedle-Assisted Transdermal Delivery of Naloxone for Opioid-Induced Pruritus.
    Gao X; Brogden NK
    J Pharm Sci; 2019 Nov; 108(11):3695-3703. PubMed ID: 31476312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.